Monday, December 14, 2009

Swine Flu Virus & Vaccines (Part 2)


New Doubt Cast on True Cause of Deaths in 1918-19 Flu Pandemic
Posted by Dr. Mercola
April 06 2010
A researcher who authored one of the first articles connecting aspirin to Reye’s Syndrome, a lethal disease that attacks the liver and brain, is suggesting that aspirin also could be to blame for a significant portion of deaths in the 1918-1919 influenza pandemic.
In an article in Clinical Infectious Diseases, California internist Dr. Karen M. Starko talks about the high doses of aspirin that were used to treat fever and the aches and pains of the early 20th century flu.
The symptoms of aspirin overdoses, she says, may have been difficult to distinguish from those of the flu, especially among those who died shortly after they became ill.
This information is particularly relevant today, not only because CDC officials are pushing for people to get the H1N1 shot before they go on spring break, but also because they have now decided that H1N1 will be part of the seasonal flu shot scheduled for the 2010-11 flu season.
They also have expanded the flu shot schedule to include the elderly and infants 6 months of age and older.
New York Times October 13, 2009 (see below)
Science Daily October 3, 2009 (see below) March 5, 2010
Dr. Mercola's Comments:
No one will ever know whether aspirin therapy was actually a culprit in the deaths of the 1918 pandemic. But the history lesson is important, especially since the 1918 pandemic is being used as a benchmark to fuel flu fears today.
Even as world health officials sit with egg on their faces, pondering why the 2009 H1N1 swine flu proved not to be the pandemic they predicted, they still insist people get vaccinated, even though the flu season is mostly over. And in a sky-is-falling move, they’ve also decided to include H1N1 in the seasonal flu vaccines for 2010-2011.
I have already commented on the hyped-up H1N1 numbers that the US was reporting during the “height” of this non-pandemic. The lid was blown off by CBS investigative reporter Sharyl Attkisson, who revealed that the vast majority of “swine flu” cases were not H1N1 at all -- but, rather, some sort of respiratory infection.
In other words, it was flu-like-symptoms -- not flu of ANY kind -- that was making people sick during the so-called H1n1 “pandemic.” The reason H1N1 numbers were so high was because the CDC had instructed health care officials to stop testing for H1N1, and just presume that everyone who showed up with flu-like symptoms was infected with H1N1.
It was a great game plan. Only it didn’t work because some health officials tested anyway, and found out the truth.
Finally, a few weeks ago in February, after months of waiting for the hundreds of thousands of H1N1 deaths that didn’t come, the World Health Organization admitted to Business Week magazine that "the overwhelming expression of [H1N1] was mild," and that they were going to use the pandemic-that-wasn’t as a learning tool.
Apparently, what they learned is that, like it or not, H1N1 is going to be part of your flu shot package from now on.
History, Big Pharma, and the Flu
Before I talk about what the new flu shot recommendations mean let’s go back to that 1918 flu, and look at how a pharmaceutical company may have contributed to countless deaths.
As Dr. Starko’s research shows, some doubts about the causes of the 1918 flu deaths that were raised at the time. At least one pathologist thought that the amount of lung damage seen during autopsies was too little to attribute to viral pneumonia (a complication of the flu), and that the large amounts of bloody, watery liquid in the lungs must have had some other cause.
Without autopsy reports or other documents, Dr. Starko cannot definitively prove that aspirin was that other cause, but aspirin overdose stands out because the symptoms of aspirin overdose are similar to what that turn-of-the-century pathologist observed, she writes.
It also fits historically. Back then, aspirin was a fairly new drug, and its maker, Bayer, was advertising it heavily. Since aspirin packages had no warnings on them, and came with little or no instructions on dosages. All people really knew was that they could take this drug and feel better quickly.
So at the time people were taking large doses of Bayer aspirin. As Dr. Starko notes, when the flu popped up in late 1917 in Europe, the US Surgeon General and the US Navy began recommending aspirin to help alleviate flu symptoms for soldiers. Then, as the flu moved to the US, civilians followed suit.
With encouragement from the respected Journal of the American Medical Association, people downed 1,000-milligram doses of the drug every three hours, which today is the equivalent of downing 25 standard 325 milligram tablets in a 24-hour period.
The recommendations for this aspirin flu therapy came from government and health officials just before the October 1918 flu death spike, Dr. Starko says.
This level of high aspirin dosage is now known to, in some cases, cause toxicity and build-up of fluid in the lungs, which Dr. Starko theorizes may have contributed to the incidence and severity of symptoms, bacterial infections, and mortality, back then.
History Repeating Itself?
Anyone who has a child probably already knows that you’re not supposed to give aspirin to sick children, because of the possible risk of Reyes Syndrome, a serious disease that can cause swelling in the liver and brain.
Reyes Syndrome most often affects children and teenagers, but it also can affect adults -- and when was the last time your health care provider told you not to give aspirin to your teenager, or not to take aspirin yourself when you are sick?
good reminder not to take aspirin for cold or flu symptoms
Since many people grab the aspirin bottle first when they’re not feeling up to par, it’s possible that more than a few people this past fall and winter did just that when they felt a cold or flu symptoms coming on.
It just makes me wonder if, like the 1918 flu, aspirin could have been partly to blame for all the “flu-like symptoms” reported to health officials during this past flu season?
Like the 1918 flu, it’s a question that we’ll never know the answer to. But it is a good reminder not to take aspirin for cold or flu symptoms.
Spring Break and Next Fall: Recycling the Leftovers
In the meantime, with flu season mostly over, and with plenty of unused H1N1 vaccine left on their shelves, the CDC has partnered with the American College Health Association to encourage students, faculty, and staff at colleges and universities to get vaccinated against the H1N1 flu virus for spring break.
Saying that the 2009 H1N1”pandemic” will continue for weeks, the CDC is urging the college crowd to get vaccinated right away.
At the same time the college letters came out, the CDC began predicting “a wave of flu activity” yet to come nationwide, and possibly even worldwide, even though the flu season is mostly over. On its website, it also warned that additional flu waves may come as late as May, with sporadic cases throughout the summer.
Anticipating that maybe this time the CDC and the WHO are correct -- that H1N1 will hang around to become a pandemic later -- the Advisory Committee on Immunization Practices (ACIP) announced a provisional, updated recommendation regarding H1N1 vaccination on its website.
For the upcoming 2010-2011 flu season, the ACIP says, H1N1 will be part of a trivalent shot that includes two regular flu viruses, along with H1N1.
Another important change for the coming year is that no one older than 6 months is exempt from flu shots anymore -- the new rules state that everyone, including all children ages 6 months and up, as well as the elderly, should get flu shots from now on.
And watch out, senior citizens, because if you get this vaccine you’ll be getting a quadruple hit. Posted March 2, the ACIP says:
A higher dose formulation of an inactivated seasonal influenza vaccine (Fluzone High-Dose, manufactured by Sanofi Pasteur, licensed by FDA on December 23, 2009) for use in people age 65 years and older will be available in the 2010-11 influenza season.
Fluzone High-Dose contains four times the amount of influenza antigen compared to other inactivated seasonal influenza vaccines.
Fluzone High-Dose vaccine in one study of people age 65 years and older produced higher antibody levels, but slightly higher frequency of local reactions.
Studies are underway to assess the relative effectiveness of Fluzone High-Dose compared to standard dose inactivated influenza vaccine, but results from those studies will not be available before the 2010-11 influenza season.
I added the boldface type to the ACIP’s notice, to call attention to what our government health officials are recommending for senior citizens, some of whom may be in fragile health already: FOUR times the amount of antigen, of which the studies WILL NOT BE AVAILABLE before the vaccines are given.
This means that, once again, the public is being asked to be the guinea pig for a drug company’s final clinical trial.
One More Time, the Evidence Shows Flu Shots Don’t Work
Aside from the fact that a new Cochrane Systematic Review says that there is poor evidence that influenza vaccines work in the elderly, and that there is little or no evidence that they even work at all, a different study shows that flu vaccines don’t work in children either.
This study, published in the October 2008 issues of JAMA and JAMA’s Archives of Pediatrics & Adolescent Medicine, looked at children younger than age 5 who were seen in hospitals, emergency rooms or physicians’ offices during the 2003-2004 and 2004-2005 flu seasons.
It found that use of the influenza vaccine was NOT associated with preventing hospitalizations or reducing visits to their pediatricians. I commented on this study when it first came out. But in case you missed it, here’s what the study showed:
“Significant influenza vaccine effectiveness could not be demonstrated for any season, age or setting after adjusting for county, sex, insurance, chronic conditions recommended for influenza vaccination and timing of influenza.”
The authors speculated that vaccinated children in this study got the flu anyway, because the vaccines for those years did not contain the actual flu virus that was going around – something that can happen in any year, since world health officials and manufacturers have to guess ahead of time which flu might be the predominant one in an upcoming year.
And finally, for more proof that there’s no evidence that flu vaccines work, then why not hear it straight from the horse’s mouth – the vaccine manufacturers themselves. For example, here are excerpts from the actual package inserts of the four flu vaccines that the CDC and ACIP are recommending for this coming fall:
Fluzone High-Dose: There have been no controlled clinical studies demonstrating a decrease in influenza disease after vaccination with Fluzone High-Dose.
Agriflu: No controlled efficacy trials have been performed to indicate a decrease in influenza disease after vaccination with AGRIFLU.
Afluria: There have been no controlled clinical studies demonstrating a decrease in influenza disease after vaccination with AFLURIA.
Fluarix: Specific levels of hemagglutination-inhibition (HI) antibody titer post-vaccination with inactivated influenza virus vaccines have not been correlated with protection from influenza illness but the HI antibody titers have been used as a measure of vaccine activity.
While Fluarix’s wording is technical, it essentially is saying the same thing as the others: no clinical trials have been done to prove that these vaccines will keep you from getting the flu -- the only thing they have to go on is a measurement of antibodies to the specific flu virus in the blood of trial subjects.
And even then, it’s anybody’s guess whether the vaccine actually will protect you from the flu -- just like that children’s trial published in JAMA proved.
Compelling Evidence Not to Opt for the H1N1 Shot
If that’s not enough to make you wonder why the CDC continues to come out almost daily with more flu warnings, more flu advisories, and more flu shot recommendations, then consider this little tidbit that came out just a couple weeks ago:
According to Science Daily:
“New research from Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler School of Physics and Astronomy, grounded in the study of bacteria, presents compelling evidence to suggest there may be good reasons why most people should not automatically opt for the swine flu H1N1 shot.”
The scientists used the mannerisms of the bacteria themselves to explain why people should not be so eager to jump on a new vaccine bandwagon.
"The simple rule we learned from bacteria is that anybody who has to make an important decision -- especially one of life and death at times of stress -- should wait to see the trend of changes, process the risks and odds in depth, and only then decide," says Prof. Ben-Jacob.
Proof that Vitamin D is the Best Flu ‘Vaccine’ Around
I couldn’t have said it better myself. But I saved the best for last. For years now, I’ve been talking about how important vitamin D is to your overall good health, and how it can help you in warding off illnesses like the flu.
I’ve cited numerous studies supporting my stand on vitamin D, but this one, published March 10, 2010 in the American Journal of Clinical Nutrition, is a new one that reinforces everything I’ve ever said about what vitamin D can do.
In this first-ever, rigorously designed, randomized, double-blind, placebo-controlled trial on the topic, researchers investigated the effect of Vitamin D3 supplements on the incidence of seasonal influenza A in schoolchildren.
The study is recent, done from December 2008 to March 2009. What these researchers found was astounding, but not surprising: that vitamin D3 supplementation during the winter may reduce the incidence of influenza A, especially in specific subgroups of schoolchildren.
It was particularly noticeable in children with a previous diagnosis of asthma, the researchers said. In the children taking the supplements, asthma attacks as a secondary outcome of the flu were one-sixth of what they were in children not taking the supplements.
I’m thrilled that, finally, a clinical trial proves what I’ve been saying all along -- that it’s a good idea to take a natural nutrient in the form of vitamin D to help you stay healthy. Do the benefit/risk equation yourself when you compare natural vitamin D supplementation with vaccines manufactured with destructive chemicals, preservatives and adjuvants.
I’m sure this is something that the flu vaccine makers aren’t going to like.
I’m also certain you’re not going to read about it on the CDC’s website, even though, as I wrote about in this previous article, they should have already noticed that a majority of children who died this season of H1N1 had diseases associated with vitamin D deficiency.
The good news is, the information is out there, and more and more health officials are beginning to take notice, including the Canadian government which, as I wrote about last year, is also studying vitamin D’s effect on the flu.
Also See:
In 1918 Pandemic, Another Possible Killer: Aspirin
By Nicholas Bakalar
October 13, 2009
A nurse took a patient's pulse in the influenza ward at Walter Reed Hospital in 1918.
The 1918 flu epidemic was probably the deadliest plague in human history, killing more than 50 million people worldwide. Now it appears that a small number of the deaths may have been caused not by the virus, but by a drug used to treat it: aspirin.
Dr. Karen M. Starko, author of one of the earliest papers connecting aspirin use with Reye’s syndrome, has published an article suggesting that overdoses of the relatively new “wonder drug” could have been deadly.
What raised Dr. Starko’s suspicions is that high doses of aspirin, amounts considered unsafe today, were commonly used to treat the illness, and the symptoms of aspirin overdose may have been difficult to distinguish from those of the flu, especially among those who died soon after they became ill.
Some doubts were raised even at the time. At least one contemporary pathologist working for the Public Health Service thought that the amount of lung damage seen during autopsies in early deaths was too little to attribute to viral pneumonia, and that the large amounts of bloody, watery liquid in the lungs must have had some other cause.
Dr. Starko acknowledged that she did not have autopsy reports or other documents that could prove that aspirin was the problem. “There was a lot of chaos in these places,” she said, “and I’m not sure if there are good records anywhere.”
But of the many factors that might have influenced the outcome in any particular case, Dr. Starko wrote, aspirin overdose stands out for several reasons, including a confluence of historical events.
In February 1917, Bayer lost its American patent on aspirin, opening a lucrative drug market to many manufacturers. Bayer fought back with copious advertising, celebrating the brand’s purity just as the epidemic was reaching its peak.
Aspirin packages were produced containing no warnings about toxicity and few instructions about use. In the fall of 1918, facing a widespread deadly disease with no known cure, the surgeon general and the United States Navy recommended aspirin as a symptomatic treatment, and the military bought large quantities of the drug.
The Journal of the American Medical Association suggested a dose of 1,000 milligrams every three hours, the equivalent of almost 25 standard 325-milligram aspirin tablets in 24 hours. This is about twice the daily dosage generally considered safe today.
Dr. Starko’s paper, published in the Nov. 1 issue of Clinical Infectious Diseases, has stirred some interest, if not enthusiastic endorsement, among other experts.
“I think the paper is creative and asking good questions,” said John M. Barry, author of a book on the 1918 flu titled “The Great Influenza.” “But we don’t know how many people actually took the doses of aspirin discussed in the article.”
The pharmacology of aspirin is complex and was not fully understood until the 1960s, but dosage is crucial. Doubling the dose given at six-hour intervals can cause a 400 percent increase in the amount of the medicine that remains in the body. Even quite low daily doses — six to nine standard aspirin pills a day for several days — can lead to dangerously high blood levels of the drug in some people.
Peter A. Chyka, a professor of pharmacy at the University of Tennessee, said he found Dr. Starko’s theory “intriguing.” Little was known about safe dosages at the time, he said, and doctors often simply raised the amount until they saw signs of toxicity.
“In the context of what we know today about aspirin and aspirinlike products, Starko has made an interesting effort to put this together,” Dr. Chyka said. “There are things other than flu that can complicate a disease like this.”
Although he doubted that more than a small number of deaths could be attributed to aspirin overdose, Dr. David M. Morens, an epidemiologist with the National Institutes of Health, said the paper was valuable in that “it makes an attempt to look at environmental or host factors that may be involved.” He said, “We haven’t been able to explain all the deaths in young adults with the virus itself.”
Dr. Starko was hesitant to estimate how many deaths aspirin overdose could have caused, but suggested that military archives might be one place to look. “I’m hoping others will follow up,” she said, “by examining available treatment records.”
Also See:
Aspirin Misuse May Have Made 1918 Flu Pandemic Worse
ScienceDaily (Oct. 3, 2009) — The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
High aspirin dosing levels used to treat patients during the 1918-1919 pandemic are now known to cause, in some cases, toxicity and a dangerous build up of fluid in the lungs, which may have contributed to the incidence and severity of symptoms, bacterial infections, and mortality. Additionally, autopsy reports from 1918 are consistent with what we know today about the dangers of aspirin toxicity, as well as the expected viral causes of death.
The motivation behind the improper use of aspirin is a cautionary tale, said author Karen Starko, MD. In 1918, physicians did not fully understand either the dosing or pharmacology of aspirin, yet they were willing to recommend it. Its use was promoted by the drug industry, endorsed by doctors wanting to “do something,” and accepted by families and institutions desperate for hope.
“Understanding these natural forces is important when considering choices in the future,” Dr. Starko said. “Interventions cut both ways. Medicines can save and improve our lives. Yet we must be ever mindful of the importance of dose, of balancing benefits and risks, and of the limitations of our studies.”
17 serious illnesses from H1N1 vaccine under investigation
Posted By Sharon Lem, QMI Agency
Posted 04 February 2010
TORONTO -The provincial health ministry is investigating 17 cases where people fell seriously ill after the receipt of the H1N1 flu vaccine.
Andrew Morrison, spokesman for the Ministry of Health and Long Term Care, said the cases include four vaccine recipients who came down with Guillain- Barre Syndrome (GBS) -- a rare neurological condition characterized by sudden weakness or paralysis. Another 13 people came down with anaphylaxis, a serious allergic reaction which can include symptoms of anaphylactic shock, rapid heartbeat, itchiness in the skin and difficulty breathing.
Donna Hartlen, a 39-year-old Markham mother, was diagnosed with GBS two weeks after receiving a shot of the vaccine.
She is partially paralyzed on the right side of her face. She is no longer able to properly chew food and her right eye is bandaged because she can no longer blink to protect it.
Don Gibson, 80, also of Markham, who also developed GBS, said he received the same batch of H1N1 flu vaccine two days before Hartlen from the same Markham doctor's office.
Gibson said it's too coincidental and also blames the H1N1 vaccine for his GBS infection.
Morrison said there are measures in place to watch for severe allergic reactions following the administering of vaccines.
"It may be difficult to conclusively say whether it's one or another cause because there are a number of ways you can be infected such as through food-borne bacteria or surgery or the vaccine, but it's difficult to nail down, but we are looking into the four cases," Morrison said.
"There's a one in 1 million chance a person will develop GBS after getting the H1N1 flu shot. There's about 140 in every 10 million people affected by GBS in any given year," Morrison added.
Health Canada has pulled a batch of the swine flu vaccine -- produced by Glaxo- SmithKline Inc. -- after it appeared that the batch may have caused higher rates of severe allergic reactions than other lots.
No one knows why GBS affects some people and not others.
Bill and Melinda Gates make $10bn vaccine pledge
Microsoft founder Bill Gates and his wife Melinda have said they will donate $10bn (£6.2bn) over the next 10 years to develop and deliver new vaccines.
BBC News
29 January 2010
Mr Gates, speaking at the World Economic Forum in Davos, Switzerland, said the aim was to see 90% of children in developing countries immunised.
Over the past 10 years, the couple's charity has committed $4.5bn (£2.78bn) to the development of vaccines.
The World Health Organization called the commitment "unprecedented".
Mr Gates said that by increasing immunisation coverage in poorer countries to 90% it should be possible to save the lives of 7.6 million children under five between 2010 and 2019.
'Incredible impact'
"We must make this the decade of vaccines," he said in a statement.
"Vaccines already save and improve millions of lives in developing countries. Innovation will make it possible to save more children than ever before."
He said money was needed to make the most of new vaccines now becoming available, including ones against severe diarrhoea and pneumonia.
Melinda Gates added: "Vaccines are a miracle. With just a few doses, they can prevent deadly diseases for a lifetime.
"We've made vaccines our number one priority at the Gates Foundation because we have seen first hand their incredible impact on children's lives."
Margaret Chan, head of the World Health Organization, said it was an unprecedented contribution and urged governments and private donors to add to the initiative.
"An additional two million deaths in children under five years could be prevented by 2015 through widespread use of new vaccines and a 10% increase in global vaccination coverage," she said.
Officials say kids need second dose of H1N1 vaccine
Posted by Traci Capellman
Posted: Jan 21, 2010
Indiana health officials say more than 160,000 children across the state are overdue for a second dose of the swine flu vaccine.
That's more than half of the children who received the first dose.
The second dose is recommended to fully protect children against the swine flu.
That's one of the reasons the Elkhart County Health Department has been going into the elementary schools to do the second round of the kids shots.
Next Friday, they'll be finished with the schools.
Gwen Jaeger, Manager of Nursing Services for the Elkhart Health Department says,
"Right now, for the second shot, we've given approximately 37-thousand shots to the kids under ten, nine and under and then we're also holding public clinics and we're gonna start going out to larger employers."
Jaeger says they're also going to start making the rounds of the assistant livings with the vaccine.
As for St. Joseph County, they tell us they will have offered second doses at all public schools by the middle of March.
H1N1 swine flu hoax falls apart at the seams
by Mike Adams
Wednesday, January 20, 2010
(NaturalNews) The great swine flu hoax of 2009 is now falling apart at the seams as one country after another unloads hundreds of millions of doses of unused swine flu vaccines. No informed person wants the injection anymore, and the entire fear-based campaign to promote the vaccines has now been exposed as outright quackery and propaganda.
Even doctors are now calling the pandemic a complete hoax. As reported on FoxNews, Dr. Wolfgang Wodarg, a leading health authority in Europe, says that drug companies "organized a 'campaign of panic' to put pressure on the World Health Organization (WHO) to declare a pandemic. He believes it is 'one of the greatest medicine scandals of the century,' and he has called for an inquiry." (,2933...)
H1N1 swine flu was never dangerous, and it never should have been escalated to a level-six pandemic in the first place. It was all a big marketing scam whose purpose was to simply sell vaccines. (And the CDC and WHO were in on it...)
And it worked! Big Pharma made out with billions of dollars in profits for a useless vaccine that's now being dumped by the truck load. These vaccines were, of course, paid for with taxpayer dollars, making the Great Swine Flu Hoax of 2009 nothing more than an elaborate financial scam whose goal was to transfer wealth from the People to the shareholders of Big Pharma.
In just the fourth quarter of 2009, GlaxoSmithKline shipped $1.4 billion worth of vaccines. (
That's $1.4 billion worth of taxpayer dollars, by the way. Dollars that could have been spent on nutrition or real health education. $1.4 billion worth of free vitamin D supplements would have done far more to protect public health than vaccines could ever hope to accomplish.
A bailout for Big Pharma
Wall Street hucksters have nothing on Big Pharma, the CDC and the WHO, all of which conspired to mislead the public and generate irrational fear in order to make money selling people vaccine shots they never needed in the first place.
The drug companies raked in billions of dollars in revenues while providing a product that offered absolutely no net reduction in mortality. In fact, as the long-term side effects of the vaccines remain unknown, it could turn out that the vaccines actually result in a net increase in mortality.
Meanwhile, countless people were harmed by the swine flu vaccine frenzy (it's "countless" because nobody's counting). In addition to those who were nearly paralyzed after receiving the vaccine shots, grade school staffers in Massachusetts who lined up to receive swine flu vaccine shots were instead injected with insulin. (Insulin injections can put you into a coma.) (
The school sent a letter home to staffers and parents blaming the mishap on the school nurse. But if they weren't injecting people with a useless vaccine for a non-pandemic, none of this would have happened in the first place. (Editor's note: The press originally reported this story as "children" being injected with insulin, but they later changed their report to "staffers." This paragraph has been updated to reflect that change.)
Total swine flu deaths for 2009 were far lower than the number of deaths from regular seasonal flu. And yet it turns out that thousands of Americans who died from the swine flu had been previously injected with the vaccines ( In fact, according to calculations derived from official CDC estimates, thousands of vaccinated Americans died from swine flu anyway. The vaccines, it seems, don't really work after all. You're just as safe doing nothing.
WHO Advisor Secretly Pads Pockets with Big Pharma Money
Posted by: Dr. Mercola
January 07 2010
A Finnish member of the World Health Organization board, an advisor on vaccines, has received 6 million Euros for his research center from the vaccine manufacturer GlaxoSmithKline.
Although WHO promises transparency, this conflict of interest is not available for the public to see at WHO’s homepage.
Professor Juhani Eskola is the director of the Finnish research vaccine program and a new member of the WHO group ‘Strategic Advisory Group of Experts’ (SAGE).
SAGE recommends which vaccines -- and how many -- member countries should purchase for the pandemic.
According to documents acquired through the Danish Freedom of Information Act, Eskola’s Finnish institute, THL, received almost 6.3 million Euros from GlaxoSmithKline (GSK) for research on vaccines during 2009. GlaxoSmithKline produces the H1N1-vaccine ‘Pandemrix,’ which the Finnish government -- following recommendations from THL and WHO -- purchased for a national pandemic reserve stockpile.
Several other WHO experts also have financial ties to the pharmaceutical industry--a double role that notably is not published by WHO.
Dr. Mercola's Comments:
The World Health Organization (WHO) proclaims itself to be an agency that “is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.”
If this is the kind of leadership they offer, you should run the other direction!
The more than 6.3 million Euros (equating to over 9 million American dollars) the WHO’s research center received from GlaxoSmithKline represents the vaccine program’s number one income source.
To which they respond, “We are aware that there appears to be a conflict interest.”
And this is on the heels of a major WHO scandal involving accusations by Austrian journalist Jane Burgermeister that the WHO conspired with Baxter International (a vaccine manufacturer) and the United Nations to produce and release live bird flu virus in 2009, in an effort to trigger a pandemic.
Burgermeister has accused them of “planning to commit mass murder.”
WHO’S Who in Government Corruption
As the Flu Case article states, this financial conflict of interest is not an isolated incident with one researcher—the following list of WHO researchers, reported to have financial ties to Big Pharma, suggests a more systemic corruption:
• Dr. Peter Figueroa, Professor in the Department of Community Health and Psychiatry in Jamaica, has received money from Merck
• Dr. Neil Ferguson has received funding from Baxter, GlaxoSmithKline, and Roche, as well as from some insurance companies
• Professor Malik Peiris in Hong Kong has received money from Baxter GlaxoSmithKline and Sanofi Pasteur
• Dr. Arnold Monto, advisor to Chiron, GlaxoSmithKline, MedImmune, Roche, Novartis, Baxter and Sanofi Pasteur, has received funding from same
• Dr. Friedrich Hayden, consultant to MedImmune and Sanofi Pasteur, received money from those companies, in addition to Roche, RW Johnson, and SmithKline Beecham
Introducing Dr. Flu
And then there is Dr. Albert Osterhaus, nicknamed “Dr. Flu” because he is head of the European Scientists Fighting Influenza within the WHO.
Dr. Osterhaus is a Dutch physician who has been very active in promoting mass vaccination through WHO and the Western media[i]. The government of the Netherlands is currently conducting an emergency investigation into the activities of “Dr. Flu” since it was recently discovered that he has been receiving a salary from several swine flu vaccine companies.
Dr. Osterhaus has received funding from Baxter, Crucell, Novartis, Hoffman-La Roche, MedImmune, Nobilon, Sanofi Pasteur, MSD, GlaxoSmithKline, and Solvay.
The WHO is in the powerful position of reviewing and making vaccine recommendations to the world. Tom Jefferson, professor of epidemiology at the Cochrane Center in Rome, aptly states:
“It is disturbing that many of the scientists who sit on various committees of WHO, are presented as ‘independent experts’, but they carefully conceal the fact that they receive money from pharmaceutical companies.”
Dr. Jefferson goes on to tell reporters:
“The WHO is biased in their recommendations. Normal hygiene measures provide much greater effect than these little-studied vaccines, and at the same time WHO refers to the use of masks and hand-washing as a means to combat swine flu only twice in their documents. Vaccines and other medications are referred to 42 times!”
But hand washing never made anyone wealthy.
Dr. Jefferson and several of his colleagues believe that paid advisers of the pharmaceutical companies should be removed from their positions and not allowed to give recommendations to the WHO.
I couldn’t agree more. But the organization itself is in no hurry to carry out such reform.
The Evil Geniuses of Big Pharma
The WHO is not unique in its vulnerability to the influence of Big Pharma.
Washington teems with a thousand industrial lobbyists. They cluster around the band of luxury offices and expensive restaurants that stretches from the White House to the Capitol building--a two-mile axis along which money and power are constantly traded.
In this pantheon of corporate muscle, no industry wields as much power as the Pharmaceutical Research and Manufacturers Association (PhRMA), a pressure group renowned for its deep pockets and aggression, even by the standards of U.S. politics.
There is also a perpetual revolving door between government and the pharmaceutical industry—more and more key government positions are filled with people living “double-lives” with drug/healthcare companies:
• President Obama’s nominee at the Department of Homeland Security overseeing bioterrorism defense, Dr. Tara O’Toole, has served as a key advisor for a lobbying group funded by a pharmaceutical company that has asked the government to spend more money for anthrax vaccines and biodefense research[ii].
• Tom Daschle—the former Democratic senator from South Dakota and Senate Majority Leader—who was President Obama’s first pick for secretary of health and human services. Daschle’s work included being a paid advisor for a lobbying law firm that earned $16 million representing some of the healthcare industry’s most powerful interests.Of course, as you might recall, this nomination didn’t fly.
• Senior Advisor David Axelrod is accused of collecting big money from Big Pharma to pass healthcare reform by way of his former partners at a Chicago-based firm called AKPD Message and Media. In fact, he founded the firm, and his son is still employed there.[iii]
These are but a few examples—there are many more to be found.
To quote Democratic congressman Sherrod Brown:
“The PhRMA doesn’t need to lobby. The industry is in the While House already.”
Drug giants not only specialize in influencing government officials, but they also have the ordinary physician in their grips.
The practice by drug companies of lavishing gifts upon doctors—far beyond pens and mugs—including exclusive vacations, “consulting” agreements that involve little work and other freebies—is gaining increased scrutiny and disapproval in the public’s eye.
Even more quietly, another practice is growing in popularity.
This devious ploy involves private-practice physicians setting up tax-exempt charities, which then receive major donations—to the tune of millions of dollars a year—from drug companies and medical device makers. The “charities” then typically conduct medical research or education, which the physicians behind them promote as being legitimate.
Increasingly, Big Pharma spends billions to influence what doctors see, read and hear, often persuading them to prescribe more drugs, just as it spends billions to taint researchers’ decision-making process.
A national survey of physicians published in the New England Journal of Medicine in 2007, well-known and often quoted, found that 94 percent of physicians have a “relationship” with the pharmaceutical, medical device, or other related industries.
This massive conflict of interest has prompted Senators Chuck Grassley and Herb Kohl to introduce a bill called the Physician Payment Sunshine Act, which would require physicians to report annually to the government all payments over $100, beginning in 2010, and that information would be made available to the public.
What’s the Cost of Pushing Pills These Days?
Exactly how much does the pharmaceutical industry spend to push its products?
A study in 2008[iv] endeavored to measure those costs, and the results are staggering.
They calculated that Big Pharma spends almost twice as much on promotion as they spend on research and development:
1. The industry spent $57.5 billion on marketing and promotion in 2004. (This estimate far exceeds the $20 billion estimated by the research firm called Integrated Medical Systems (IMS), which is most often quoted.)
2. The amount spent on research and development pales in comparison, at $31.5 billion.
Add to that what the industry spends in lobbying, and it adds up to a mind-numbing figure.
These numbers clearly demonstrate the need for redirecting the priorities of the industry toward more research and less marketing, besides the need for quashing the greed and corruption that run so rampant within it.
“Trust Allah, But Tie Up Your Camel”
Until the umbilical cord between Big Pharma and the government is cut, healthcare/health policy reform will remain a dream. Until then, take what your government and your physician tell you with a grain of salt.
Trust but verify.
Remain proactive, educating yourself on these issues rather than simply believing the press releases that are reiterated a hundred times on every cable channel.
With respect to the swine flu, I recommend spending a little time reviewing the vast supply of information available on the National Vaccine Information Center (NVIC) site, if you haven’t already done so.
Most Britons Reject Swine Flu Vaccine
Posted by: Dr. Mercola
December 08 2009
More than half of Britons being offered vaccination against pandemic H1N1 flu are turning it down because they fear side effects or think the virus is too mild to bother.
A survey of more than 100 family doctors indicated that there was widespread resistance from patients, and that on average only 46 percent of those offered the vaccination agree to have it.
Doctors reported particular difficulties in persuading pregnant women to be vaccinated against the virus.
Skepticism has been growing in Britain and other European countries about health authorities' handling of the H1N1 pandemic, because the number of people infected has been lower than originally feared.
Further, rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, according to a new report by Quest Diagnostics.
As U.S. health officials struggle to vaccinate tens of millions of Americans against the pandemic of swine flu, some are now even looking regretfully at one easy way to instantly double or triple the number of doses available -- by using an immune booster called an adjuvant.
These additives broaden the body's response to a vaccine, reducing the amount of active ingredient called antigen needed. They are widely used in European flu vaccines as well as in Canada. But not in the United States -- even though the federal government has spent nearly $700 million buying them.
The reason -- people might not trust them.
Polls show that only about half of Americans plan to be vaccinated against H1N1. Of those who do not, about half say they worry about safety.
Further, The World Health Organization is looking into reports in Britain and the United States that the H1N1 flu may have developed resistance to Tamiflu in people with severely suppressed immune systems.
Britain's Health Protection Agency (HPA) said five cases have been confirmed in Wales of patients infected with H1N1 resistant to Tamiflu.
Dr. Mercola's Comments:
The massive swine flu vaccination propaganda push seems to be falling on deaf ears, or perhaps more accurately, is being squelched by informed people making the wise, common sense decision to avoid becoming an H1N1 vaccine guinea pig.
Echoing the majority of Britons who have decided to skip the swine flu vaccine, nearly 7 out of 10 Americans in the 18-29 age bracket said they will not get the H1N1 vaccine, according to an ABC News-Washington Post poll on October 22. Ditto for 62 percent of those aged 30-64, and 53 percent of seniors, aged 65 and over.
But this doesn’t mean the hard-sell vaccine push is over. Far from it.
Even as Quest Diagnostics’ Health Trends Report showed that H1N1 cases appear to have peaked in October, with rates of positive H1N1 test results declining in nearly all age groups and most U.S. regions since late October, the CDC still recommends getting vaccinated.
If you are one of those people still on the fence, trying to decide whether or not you should get the H1N1 vaccine for yourself or your child, I urge you to read my previous article, CBS Reveals that Swine Flu Cases Seriously Overestimated, if you have not already done so, to get a much clearer picture of this overhyped threat.
For example, according to the CBS News investigation, when you come down with chills, fever, cough, runny nose, malaise and all those other "flu-like" symptoms, the likelihood of the illness being caused by influenza is, at most, 17 percent of the time, and as little as 3 percent!
The other 83 to 97 percent of the time it's caused by other viruses or bacteria.
Based on this fact, and the fact that the CDC changed the way they count “H1N1 cases” as of the end of August, to now include any and all “flu-like symptoms,” it’s quite possible that current mortality statistics are exaggerated by as much as 80-90 percent, or more!
Is the Vaccine Even Effective?
If you read through the package inserts for the injectable, inactivated flu vaccines, you will find the following paragraph:
"Specific levels of HI antibody titers post-vaccination with inactivated influenza virus vaccine have not been correlated with protection from influenza virus. In some human studies, antibody titers of 1:40 or greater have been associated with protection from influenza illness in up to 50% of subjects."
What that paragraph explains is that, to the best of our knowledge, the vaccine only works in half, or less, of those individuals who attain the specified level of seroconversion after vaccination.
The FDA defines seroconversion as achieving an antibody titer of 1:40.
This means that if a vaccine was 100 percent effective at achieving this level of seroconversion, it would protect up to 50 percent of the recipients of the vaccine.
But none of the vaccines are 100 percent effective at achieving seroconversion.
CSL's vaccine insert, for example, states that their H1N1 vaccine provides seroconversion for:
48.7 percent of people aged 18-65
34 percent for seniors, 65 and older
That means that, at best, their vaccine produces antibody levels in one out of every four people!
The vaccine does NOT work in three out of every four people
Which, of course, means that the vaccine does NOT work in three out of every four people…
Is a 25 percent chance of reaping any sort of benefit worth the risk? For a mild, over-hyped illness?
The Heartbreaking Side Effects of the H1N1 Vaccine are Beginning to Surface
This past article contains personal stories of heartbreak -- pregnant women who lost their babies just hours or days after getting the H1N1 vaccine this year.
Naturally, the standard comeback is that miscarriages are commonplace, and surely have nothing to do with the vaccine. However, to simply dismiss these events as “coincidences” is a serious mistake.
Perhaps some of the 20 women on one of the blogs would have miscarried anyway, but when a number of women have healthy, uneventful pregnancies up until they’re injected with a vaccine, and then suddenly miscarry, it most certainly warrants investigation!
Meanwhile, Jordan McFarland, a 14-year-old boy from Virginia, is weak and struggling to walk after coming down with a reported case of Guillain-Barre syndrome (GBS) within hours after receiving the H1N1 vaccine for swine flu.
At the beginning of November, a 42-year-old Quebec woman died two days after receiving the H1N1 vaccine. But did authorities report it as an adverse reaction to the vaccine?
No! Instead, they attributed her death to complications resulting from the H1N1 virus!
I suppose they did this because she developed flu-like symptoms. What they didn’t say was that flu-like symptoms are also some of the adverse reactions you get from receiving a flu shot.
They also didn’t say that other reactions can include Guillian-Barre Syndrome (GBS) convulsions, syncope (fainting), blood and lymphatic system disorders, and immune disorders such as anaphylaxis, just to name a few – all events that can be life-threatening enough to end in death.
It’s no surprise, then, that when an 80-year-old man died in Quebec after getting his H1N1 vaccine, health officials dismissed that too, saying it was too soon to link his death to the shot.
Get the Facts Before You Get the Vaccine
The mainstream press just keeps plugging the same old propaganda, disregarding what is actually happening.
The truth is, while the mortality rate of swine flu is extremely low, what is happening is that people are dying or suffering life-altering disabilities shortly after receiving the flu vaccine, whether it’s seasonal or H1N1 -- and officials accept this as the cost of doing business.
But do you?
I suggest that before you take this shot, ask your doctor to supply you with a package insert from the vaccine, and to discuss all the possible adverse reactions with you. Any health professional should be able to do this -- in fact, it is part of something called “informed consent,” which is required for any medical procedure, including each and every vaccination.
But just in case your doctor doesn’t have the insert handy, or has forgotten about informed consent, you can find four of the five inserts here. I predict that what you learn there will not be something you read in your local newspaper.
Swine Flu is NOT the Problem -- It is the Vaccine that May Harm or Kill You
Posted by: Dr. Mercola
November 08 2009
You’ve probably noticed the escalating hype and hysteria surrounding the swine flu pandemic as colder months approach and the number of worldwide cases climbs.
It’s true the virus is spreading.
Much more important, however, is the fact that reported cases continue to be symptomatically mild, requiring little or no medical intervention. And deaths from the H1N1 virus remain extremely low, at less than one half of one percent of reported cases as of July 6.
Despite this fact, the United States has committed to spending another $1 billion on ingredients for an H1N1 vaccine, according to U.S. Health and Human Services Secretary Kathleen Sebelius, with plans for a mid-October vaccination program intact.
Plans are also underway to implement vaccine programs around the world. In Germany, for instance, the health ministry announced the government had plans to order 50 million vaccine units and up to 22.5 million people may be vaccinated in the first stage of the plan starting in September (even though no fatalities have occurred in the country to date).
The cost of the vaccination program is estimated at two billion euros -- even though only 800 infections, none of them fatal, have been reported in the country.
The White House Speaks About Swine Flu
If you’re on the White House email distribution list, you received an email recently announcing the “H1N1 Influenza Preparedness Summit” held on July 9. The note was signed by the Secretaries of Health and Human Services (HHS), Homeland Security, and Education.
The message said, in part:
“We are working together to monitor the spread of 2009-H1N1 and to prepare to initiate a voluntary fall vaccination program against the 2009-H1N1 flu virus, assuming we have a safe vaccine and do not see changes in the virus that would render the vaccine ineffective.”
Two things in this paragraph stand out. Number one -- the vaccination program is still voluntary. A plan for mass swine flu vaccinations is not good news, but it appears that at least for now, the choice is still up to you.
The other item which stands out in that paragraph is the phrase, “... assuming we have a safe vaccine.”
How safe is a vaccine that has been developed, “tested,” and shipped for mass distribution in a matter of weeks? The answer -- it isn’t.
Unfortunately, President Obama is fully onboard with the prospect of mass injections of inadequately tested, potentially deadly vaccines.
"We want to make sure that we are not promoting panic, but we are promoting vigilance and preparation," he said during the July 9 summit, adding, "the most important thing for us to do is to make sure that state and local officials prepare now to implement a vaccination program in the fall."
Target Groups are Among the Most Vulnerable to Vaccine Risks
Yesterday's Washington Post ran a story in which 2800 people will be tested for the vaccine in 8 US cities. Even more concerning though is that they are expecting 160 million doses of the vaccine to be ready this fall with the first batch sometime this September.
As I mentioned in an earlier article, school children are the first target group to receive vaccinations. According to the Washington Post, Education Secretary, Arne Duncan said during the summit that "we would absolutely welcome" the idea that the nation's schools be turned into vaccine shot clinics. He called them "natural sites" and said that "to open our doors and be part of the solution really makes sense."
Makes sense to whom? I can’t say this enough -- if you understand the truth about vaccines it is beyond outrageous to suggest children should be the first to line up for swine flu vaccine injections.
Say NO to the Vaccine !!!
According to the World Health Organization (WHO), the most serious and fatal cases of H1N1 have occurred in people between the ages of 30 and 50, many of whom were already ill with disorders like asthma, heart problems, diabetes, autoimmune diseases and obesity.
Cases of swine flu in healthy children have been mild in nature, with little or no medical intervention required. Informed parents, given a choice, will surely opt for a mild case of the flu over the potential health risks of an inadequately tested vaccine that can potentially cause long-term devastation of your child’s health, or worse.
Further, under federal legislation passed by Congress since 2001, an Emergency Use Authorization allows any company that gives experimental vaccines to Americans during a declared public health emergency to be protected from liability if people get hurt.
It is a bad idea to turn schools into medical clinics and test experimental swine flu vaccines on children first. Especially when nobody has any liability.
The Secretary of HHS, Kathleen Sebelius, rounded out the first targeted injection group by also including healthcare workers, pregnant women, and adults with chronic illnesses.
Pregnant women and people of any age with compromised immune systems are potentially at much higher risk for complications from dangerous vaccines than they are from a mild influenza virus.
On Their Way -- Vaccines Containing the Deadly Adjuvant Squalene
Squalene Update as of October 2009:
According to Barbara Loe Fisher, founder of the NVIC, none of the H1N1 vaccines being distributed in the United States contain squalene or other oil in water adjuvants.
We successfully made enough fuss about the potential danger of fast tracking licensure of squalene adjuvants into US H1N1 vaccines under an Emergency Use Authorization (EUA) that can be invoked during a declared public health emergency that the FDA has NOT licensed these adjuvants for the U.S.
There is squalene in H1N1 vaccines licensed in Europe but not yet in the U.S. That is not to say the vaccine manufacturers will not try to get the adjuvants inserted into vaccines in the future, but for now we have won on this point.
I recently posted an article on the subject of the vaccine adjuvant squalene. If you haven’t read this article, I suggest you do so. It contains crucial information about the health risks associated with injections of vaccines containing squalene.
Adjuvants are added to vaccines to make them more “effective” and to reduce the amount of vaccine required per dose. They do this by causing your immune system to react in a powerful, unnatural and potentially dangerous way to the presence of the organism you’re being vaccinated against.
Squalene is proving to be among the worst of the worst in terms of immune adjuvants.
We know at least two of the swine flu vaccines under development by drug companies will contain the oil-based adjuvant squalene. Novartis and GlaxoSmithKline are producing those vaccines, and it’s probably just the tip of the iceberg because:
In a July 13 WHO swine flu pandemic briefing note in which they list their latest recommendations on vaccines, they state:

“In view of the anticipated limited vaccine availability at global level and the potential need to protect against "drifted" strains of virus, SAGE recommended that promoting production and use of vaccines such as those that are formulated with oil-in-water adjuvants and live attenuated influenza vaccines was important.
Translation: WHO is now specifically recommending the production and use of vaccines containing oil-based adjuvants.
Also on July 13, HHS Secretary Sebelius committed another $884 million -- in addition to the $1 billion committed in May -- to purchase two key ingredients of the H1N1 vaccines under development. The key ingredients are:
1. The antigen (the active ingredient or organism)
2. The adjuvant
Novartis, whose vaccine contains the squalene adjuvant MF59, will receive $690 million of the $884 million
The handwriting is on the wall -- H1N1 vaccines will almost certainly contain the squalene adjuvant. Sebelius hedges her bets with the following statement:
“Depending on the results of clinical studies, adjuvant could be added to a vaccine to boost the immune system’s response and potentially reduce the amount of antigen necessary for the body to recognize and fight a virus.”
Depending on the results of clinical studies? Are those the same studies that will somehow be completed in record time and inexplicably deliver results pronouncing swine flu vaccines “safe and effective?”
Your skepticism is warranted and may keep you and your family safe.
Again -- please read my recent article on squalene so you will be fully informed of the deadly potential of this vaccine adjuvant and the controversy surrounding its use.
The U.K. is Also Keen to Mass Vaccinate
The U.S. government isn’t alone in its irrational response to the H1N1 virus.
How’s this for a headline: “Swine flu vaccine to be cleared after five-day trial.”
Dr. Peter Holden, the British Medical Association’s lead negotiator on swine flu, is of the opinion that although swine flu is not causing serious illness in patients, U.K. health officials are eager to start a mass vaccination campaign, beginning with “priority groups.” Holden says the vaccinations will reduce the chances of a shortage of hospital beds because of people suffering from swine flu.
Why is the U.K. eager to vaccinate for a virus that isn’t causing serious illness? And why, if the swine flu isn’t causing serious illness, is Dr. Holden concerned about a shortage of hospital beds?
Some Do’s and Don’ts as Flu Season Approaches
Whether you believe the U.S. government is simply naïve or quite deliberate in their ongoing swine flu pandemic propaganda campaign, it is imperative you arm yourself with the facts about the H1N1 virus, vaccinations, and what you can do to protect yourself and your family.
Don’t assume because the government is promoting swine flu vaccines, they must be safe. Many vaccines with the FDA’s stamp of approval have proved to be dangerously high risk.
• The anthrax vaccine, mandated for U.S. military personnel, is not safe.
• Thimerosal, a commonly used mercury-based vaccine preservative, is not safe.
• The HPV vaccine (Gardasil), a disturbing example of how effective marketing can create a non-existent “need” for a product that is clearly unsafe.
• The last swine flu vaccine, from the 1976 “pandemic,” was unsafe. The pandemic never materialized, and more people died from the vaccine than from the swine flu.
• The FDA in its role as guardian of your family’s health is not safe.
Don’t assume your government cannot or will not mandate vaccinations or quarantines. Laws are on the books which give federal, and state and local authorities the latitude to enforce vaccine mandates, involuntary isolation and quarantine, and punitive action against those who resist.
• The Model State Emergency Health Powers Act directs the public health authority to “use every available means to prevent the transmission of infectious disease and to ensure that all cases of contagious disease are subject to proper control and treatment” (Article VI, page 26).
• Executive Order 13295: Revised List of Quarantinable Communicable Diseases gives authority to the Secretary of HHS to provide for the “apprehension, detention, or conditional release of individuals to prevent the introduction, transmission, or spread of suspected communicable diseases.”
• Executive Order 13375: Amendment to Executive Order 13295 Relating to Certain Influenza Viruses and Quarantinable Communicable Diseases adds “influenza caused by novel or reemergent influenza viruses that are causing, or have the potential to cause, a pandemic.”
Sign the Petition!!
If you live in the US you can sign the petition to tell your congress person that you are STRONGLY opposed to forced vaccination.
Do educate yourself about influenza strains, vaccination risks, and the public health laws in your state that may require you or your children to undergo either mandatory vaccination or quarantine.
• For a brief but comprehensive report on the history of mandatory vaccinations in the U.S. as well as the current laws in place, read the five-page CRS Report for Congress titled Mandatory Vaccinations: Precedent and Current Laws.
Do make your voice heard against mandatory swine flu vaccination programs.
• Visit the National Vaccine Information Center (NVIC) and join the fight against mandatory vaccination.
• Read about a proposed self-shielding/self-quarantine bill and send a message to your local legislator here. You can learn more about self-shielding and social distancing at this link.
Do prepare to self-shield/self-quarantine in the event of a swine flu outbreak in your area. Some suggestions:
• Store a two-week supply of food and water in the event you can’t get to a store or stores run out of supplies.
• Make sure you have a supply of any prescription drugs you take on hand.
• Talk with family members and loved ones about how they would be cared for if they got sick, or what will be needed to care for them in your home.
• Get involved in community efforts to prepare for an influenza outbreak.
Do take care of your health to reduce or eliminate your risk of contracting any strain of influenza.
A Review of Four Approved Swine Flu Vaccines’ Ingredients
Posted by: Dr. Mercola
November 05 2009
I've said it before, but I'll say it again: I'm not anti-vaccines, but rather pro vaccine-safety. That means, I strongly believe that we should only inject substances into our bodies, and especially into the bodies of infants and the unborn, that have been rigorously studied and proven safe both short-term and long-term.
As it stands now, we've spent decades injecting materials into the bodies of young and old alike, without sufficient amounts of safety testing of the ingredients, and our society is showing the signs of this neglect.
Neurological dysfunction and disorders such as autism and Alzheimer's have been growing steadily and show no signs of slowing down.
Mercury, in the form of thimerosal, is included in the majority of all flu vaccines as a preservative in multi-dose vials. Thimerosal-free single-dose vials are typically reserved for infants under the age of three, and pregnant women only.
I recently published a long list of studies confirming the health dangers of thimerosal -- proof that those who claim "thimerosal has never been shown to cause any damage" are not telling you the truth. There's plenty of evidence to the contrary, and if you missed that article, I recommend you review it now.
But thimerosal is not the only questionable and potentially dangerous ingredient in flu vaccines.
Adjuvants Explained
In order for a vaccine to be considered effective, your immune response to the vaccine should be to produce antibodies to the live or dead viruses in the vaccine (the antigen). An adjuvant is a substance added to a vaccine to improve your immune response to the antigen. The word comes from the Latin adjuvare, which means "to help."
By adding adjuvants the vaccine can contain less viral antigens, which reduces production costs.
Unfortunately, many of these adjuvants are highly toxic.
There are several types of adjuvants. Some of the most commonly used ones include:
Aluminium hydroxide
Aluminium phosphate
Calcium phosphate
Other adjuvants include oil-based emulsions such as squalene, Squalene has not been licensed by the FDA for use in vaccines distributed in the U.S. yet, although squalene is an adjuvant used in vaccines distributed in Europe and other countries.
GlaxoSmithKline's proprietary formula ASO3™ and Novartis' MF59™ are two examples of squalene adjuvants.
As damaging as the neurotoxin mercury is, it's important to realize that aluminum is also a neurotoxin and aluminum-based adjuvants are estimated to be even MORE toxic than mercury.
GREAT NEWS -- No Squalene Allowed in US Swine Flu Vaccines!
Fortunately, Americans can draw a sigh of relief as it pertains to squalene -- one of the most controversial of the adjuvants -- at least for now.
Although vaccine manufacturers were pushing to be allowed to use squalene in many of the swine flu vaccines, and the US Department of Health and Human Services purchased spent more than $400 million of tax payers' money to stockpile the oil-based adjuvant, their efforts have been unsuccessful so far.
In order to legally allow unlicensed squalene adjuvants to be included in licensed H1N1 vaccines, the US government would have had to issue an Emergency Use Authorization (EUA).
There have been small H1N1clinical trials in which experimental squalene adjuvants were included and tested, which have been reported by various media sources, fueling the questions about its use. But that is different from an FDA licensed vaccine that is made available for general public use.
To date, no EUA has been issued, so the swine flu vaccines licensed for use in the US do NOT contain squalene. However, it is still unclear whether the National Emergency declaration issued by President Obama on October 23, 2009, will cover adding novel adjuvants like squalene, or whether a separate EUA must be issued to allow the use of unlicensed adjuvants.
The best way to confirm the existence of vaccine components is to consult the vaccine product manufacturer inserts. Below, you will find links to the inserts for the four H1N1 vaccines licensed for use in the US.
You may also want to review the transcript of the July 23, 2009 meeting of the FDA Vaccines & Related Biological Products Advisory Committee for more information on the discussion about whether the FDA should issue an EUA and allow unlicensed adjuvants in US vaccines.
Thankfully, so far, the FDA has declined to approve squalene adjuvants for US H1N1 vaccines, but that does not mean that the drug companies will not continue to press for approval in the future.
Beware: European Vaccines May Contain Squalene
Unfortunately, vaccine manufacturers have persuaded countries in Europe and elsewhere to add squalene to seasonal influenza and H1N1 vaccines, so if you live outside the US, you will need to do some further research to determine which vaccines may contain squalene.
A recent article in the English version of the German news source The Local, for example, warns that the German Defense Ministry has ordered a special stock of H1N1 vaccines for their troops that will contain neither mercury nor adjuvants, whereas the general public will be given vaccines containing both.
When checking for squalene, beware that the ingredient called MF59™ is an oil-in-water emulsion of squalene, Tween™80 (polyoxyethylene sorbitan monooleate), and sorbitan trioleate.
MF59 is approved for human use in Europe, but not in the U.S.
Four Swine Flu Vaccines have Gained US FDA Approval
Below I will review the list of ingredients for the four swine flu vaccines that gained U.S. FDA approval on September 15. (As of this writing, GlaxoSmithKline is the only contracted vaccine manufacturer that has not yet gotten their swine flu vaccine approved.)
Please note that there may be additional anti-virals available that are being used to treat swine flu, and/or swine flu vaccines on the market in other countries, but this article only covers the following four vaccines that have received FDA approval for use in the US:
MedImmune (intranasal spray)
These companies, along with GlaxoSmithKline, have all been awarded contracts by the U.S. Department of Health and Human Services (HHS) for development and production of more than 195 million doses of swine flu vaccine.
For more information, warnings and side effects of each ingredient, please follow the hyperlinks provided.
MedImmune, which is a subsidiary of London-based AstraZeneca, offers an intranasal spray that contains live attenuated virus. The package insert for MedImmune's intranasal vaccine can be found here.
Please note that the adverse reaction information for MedImmune's vaccine is based on studies conducted with the seasonal flu version known as FluMist.
Please review the insert for numerous warnings, contraindications, and adverse reactions.
Of special note are the warnings that it should not be administrated to children and adolescents (2-17 years of age) receiving aspirin therapy or aspirin-containing therapy, because of association of Reye's syndrome.
In addition, it's important to realize that safety has not been established in individuals with underlying medical conditions predisposing them to influenza complications.
MedImmune's vaccine also should not be administered to any individual with asthma, or children under the age of 5 with recurring wheezing because of the potential for increased risk of wheezing post vaccination.
Lastly, please note that some viruses contained in this and other intranasal vaccines CAN spread from the vaccinated person to others. Hence, if a person has a compromised immune system, he or she could be placed at risk of infection from people who have been vaccinated. The ease of transmission appears to vary from strain to strain.
Dosing Instructions for MedImmune Intranasal Spray vaccine:
Children 0-2 years: Not approved
Children 2-9 years: 2 doses, 0.2 ml each, approximately one month apart
Children and adults between the ages of 10-49 years: 1 dose, 0.2 ml
Adults 50-65: Not approved, as FluMist was found to have no demonstrable effectiveness in this age group
Seniors 65 and over: Not approved
Pregnant women: Not recommended
Ingredients include:
Live, attenuated virus
Monosodium glutamate. MSG is a known neurotoxin and excitotoxin.
Egg proteins
Sucrose (table sugar)
Dibasic potassium phosphate
Monobasic potassium phosphate
Gentamicin sulfate (antibiotic)
Intranasal vaccines do not contain thimerosal (mercury).
Questionable Efficacy…
According to the insert, FluMist has demonstrated a mere 44.5 percent reduction in influenza rate when looking at all strains, compared to active controls (other flu vaccines).
The package insert for Novartis' Influenza A(H1N1) 2009 Monovalent vaccine can be found here.
Again, the adverse reaction information for this swine flu vaccine is based on studies conducted with the seasonal flu vaccine Fluvirin, not the A(H1N1) vaccine itself.
It is worth noting that the safety data for Fluvarin (upon which the safety data for the swine flu vaccine is based), was collected from 29 clinical studies over the past 27 years that included no more than 2,768 adults.
In these studies, the subjects were observed for 30 minutes after vaccination, and were instructed to complete a diary card for the three days following immunization, to collect local and systemic reactions.
So, keep in mind that the "safety data" for this vaccine is based on studying human subjects for FOUR DAYS. Not weeks, months, or years, to see if problems occur down the line.
Please review the insert for numerous warnings, contraindications, and adverse reactions.
Dosing Instructions (intra-muscular injection):
Children 0-4: Not recommended
Children 4-9: Two 0.5 ml doses one month apart
Children 9-17: One 0.5 ml dose
Adults, 18 and over: One 0.5 ml dose
Ingredients include:
Inactivated A/California/7/2009(H1N1)v-like virus derived from cell-cultures using dog kidneys. recently reported that a Swiss authority overseeing medicine and therapeutical products had found bacterial contamination in test batches of the vaccine -- a charge that Novartis has denied.
Single-dose vials contain 1 mcg of mercury per 0.5 ml dose
Multi-dose vials contain 25 mcg of mercury per 0.5 ml dose
Egg proteins
Polymyxin (antibiotic)
Neomycin (antibiotic found in many topical medications). Neomycin is in the FDA pregnancy category D. This means that it is known to be harmful to fetuses.
Beta-propiolactone (a disinfectant). According to the EPA: "No information is available on the chronic (long-term), reproductive, developmental, or carcinogenic effects of beta-propiolactone in humans. The International Agency for Research on Cancer (IARC) has classified beta-propiolactone as a Group 2B, possible human carcinogen."
Nonylphenol ethoxylate (NPE) (a toxic cleaning agent)
The package insert for Sanofi-Pasteur's Influenza A(H1N1) 2009 Monovalent vaccine can be found here.
The adverse reaction information for Sanofi-Pasteur's vaccine is based on studies conducted with the seasonal flu version known as Fluzone. The safety data for infants under the age of 3 is based on adverse reactions of 19 children, reported within a mere three days of vaccination.
Please review the insert for numerous warnings, contraindications, and adverse reactions.
Dosing Instructions (intra-muscular injection):
Children 0-5 months: Not approved
Children 6-35 months: two 0.25 ml doses, approximately one month apart
Children 36 months to 9 years: two 0.5 ml doses, approximately one month apart
Children 10 years and older: one 0.5 ml dose
Adults: one 0.5 ml dose
Ingredients include:
Inactivated A/California/7/2009(H1N1)v-like virus propagated in embryonated chicken eggs
Prefilled pediatric syringes and single-dose vials are mercury-free
Multi-dose vials contain 25 mcg of mercury per 0.5 ml dose
Formaldehyde (up to 100 mcg). Formaldehyde is classifed as a probable human carcinogen by the U.S. Environmental Protection Agency, and as a known human carcinogen by the International Agency for Research on Cancer.
Triton-X 100 (Polyethylene glycol P-isooctylphenyl ether) is a toxic detergent
Sodium phosphate
Sodium chloride (table salt)
Sucrose (table sugar)
CSL Biotherapies, Inc.
The package insert for CSL's Influenza A(H1N1) 2009 Monovalent vaccine can be found here.
The adverse reaction information for CSL's vaccine is based on studies conducted with the seasonal flu version known as Afluria.
Here the safety data is based on adverse reactions reported within 21 days of vaccination. It's also worth noting that the safety assessment studies were done using mercury-containing placebos, which may significantly skew the data as the control group would most likely experience similar side effects of the thimerosal as those receiving the actual vaccine.
Additionally, tucked away on page 10 it states that:
"No controlled clinical studies demonstrating a decrease in influenza disease after vaccination with Afluria have been performed."
Please review the insert for numerous warnings, contraindications, and adverse reactions.
Dosing Instructions (intra-muscular injection):
Adults only, 18 years and older: one 0.5 ml dose
Ingredients include:
Inactivated A/California/7/2009(H1N1)v-like virus propagated in embryonated chicken eggs
Single-dose vials are mercury-free
Multi-dose vials contain 24.5 mcg of mercury per 0.5 ml dose
Polymyxin (antibiotic)
Neomycin (antibiotic found in many topical medications). Neomycin is in the FDA pregnancy category D. This means that it is known to be harmful to fetuses.
Sodium chloride (table salt)
Monobasic sodium phosphate
Dibasic sodium phosphate
Monobasic potassium phosphate
Potassium chloride
Calcium chloride
Sodium taurodeoxycholate (detergent)
Egg proteins (ovalbumin)
Beta-propiolactone (a disinfectant). According to the EPA: "No information is available on the chronic (long-term), reproductive, developmental, or carcinogenic effects of beta-propiolactone in humans. The International Agency for Research on Cancer (IARC) has classified beta-propiolactone as a Group 2B, possible human carcinogen."
How Effective is the H1N1 Vaccine, Really?
"Specific levels of HI antibody titers post-vaccination with inactivated influenza virus vaccine have not been correlated with protection from influenza virus. In some human studies, antibody titers of 1:40 or greater have been associated with protection from influenza illness in up to 50% of subjects."
You will find that paragraph in all the vaccine inserts.
What that paragraph says, is that the vaccine only works in half, or less, of those individuals who attain the specified level of seroconversion after vaccination. The FDA defines seroconversion as achieving an antibody titer of 1:40.
This means that if a vaccine was 100 percent effective at achieving this level of seroconversion, it would protect up to 50 percent of the recipients of the vaccine.
But none of the vaccines are 100 percent effective at achieving seroconversion.
CSL's vaccine insert, for example, (see pages 11-12), states that their H1N1 vaccine provides seroconversion for:
48.7 percent of people aged 18-65
34 percent for seniors, 65 and older
That means that, at best, their vaccine works in one out of every four people! (49 percent of 50 percent).
Which, of course, means that the vaccine does NOT work in three out of every four people…
Is it REALLY worth it?
Final Thoughts
Hopefully, this compilation of data will help you weigh the risks and benefits, to make a more educated decision for yourself and your family.
You can also print out these fact-filled posters that we created. Feel free to share them any way you like around your community, at local stores, offices, and schools.
Lastly, please remember to bookmark the special section of my site devoted to all the latest H1N1 Swine Flu Alerts. It's an excellent go-to source to stay updated on all the new swine flu developments.
WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines
Posted by: Dr. Mercola
September 03 2009
The document on the WHO website linked below states that it is common procedure to release pandemic viruses into the population in order to get a jump ahead of the real pandemic, so as to fast track the vaccine for when it is needed.
In Europe, some manufacturers have conducted advance studies using a so-called "mock-up" vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus.
According to the website, “Such advance studies can greatly expedite regulatory approval.”
Dr. Mercola's Comments:
On June 11 the World Health Organization (WHO) raised its swine flu pandemic alert from a 5 to a 6. Phase 6 is the highest level alert, and reflects the speed with which a virus is spreading -- not its severity.
This classification also allows for a vaccine to qualify for a “fast-track” procedure for licensing and approval, and this process is now ongoing for the swine flu vaccine.
What you may not know, however, is that WHO, together with health officials, regulatory authorities and vaccine manufacturers, have been working since 2007 – long before this new “threat” of swine flu emerged – to “explore a broad range of issues surrounding the regulatory approval of pandemic vaccines.”
According to the WHO website:
“Ways were sought to shorten the time between the emergence of a pandemic virus and the availability of safe and effective vaccines.”
One such method used in Europe is to conduct advance studies using a “mock-up” vaccine that contains an active ingredient for an influenza virus that has not circulated recently in human populations.
When testing these mock-up vaccines, it is very possible to release the novel influenza virus into the population, as its purpose is to “mimic the novelty of a pandemic virus” and “greatly expedite regulatory approval.”
Government officials have other tricks up their sleeves to ensure these new, barely tested vaccines easily make it to market as well, such as:
• Labeling the vaccine a “strain change” rather than an entirely “new” vaccine. This method states the new vaccine has built on technology used to produce vaccines for seasonal influenza, and the change for the pandemic vaccine is similar to a strain change used to produce a new seasonal vaccine each flu season.
In the United States, vaccine manufacturers are required to submit fewer data if they already have a licensed flu vaccine and will use the same manufacturing process for the pandemic vaccine.
• Using a “rolling review procedure.” This allows manufacturers to submit sets of data for regulatory review “as they become available.” In other words, they’re free to distribute the vaccine and then submit the safety data later on.
Would You Want a Fast-Tracked Vaccine Injected Into Your Body?
By very definition, fast-tracked vaccines are those that have received very little safety testing prior to being used. So any time you agree to get one, you are essentially a guinea pig.
Vaccine manufacturer GlaxoSmithKline has actually stated:
"Clinical trials will be limited, due to the need to provide the vaccine to governments as quickly as possible. Additional studies will therefore be required and conducted after the vaccine is made available."
And WHO likewise says:
“Time constraints mean that clinical data at the time when pandemic vaccines are first administered will inevitably be limited. Further testing of safety and effectiveness will need to take place after administration of the vaccine has begun.”
Why would anyone who knows the facts sign up for a vaccine that really needs further safety studies … but won’t receive them until AFTER it’s already been given out? By then it will be too late.
So please realize that if you or your child receive a swine flu vaccine, you will be acting as a TEST subject.
Remember this vaccine will not be made using the methods of the past. In order to speed up the cultivation of the virus and the manufacturing process, they’re using human liver cells instead of chicken eggs. Whether this new procedure is better or worse than the old method, I can’t say … but it’s never been used before and they have not had time to conduct any human testing.
So, it’s a giant game of Russian Roulette that you simply want to avoid.
Nearly all of the vaccines created will also include thimerosal (mercury), and the toxic adjuvant squalene, both of which have been clearly shown to carry significant health risks.
You should know, too, that vaccine makers and federal officials have been rendered immune from lawsuits. Should anything go wrong with this current vaccine they will not have to pay a single cent to anyone!
Squalene Update as of October 2009:
According to Barbara Loe Fisher, founder of the NVIC, none of the H1N1 vaccines being distributed in the United States contain squalene or other oil in water adjuvants.
We successfully made enough fuss about the potential danger of fast tracking licensure of squalene adjuvants into US H1N1 vaccines under an Emergency Use Authorization (EUA) that can be invoked during a declared public health emergency that the FDA has NOT licensed these adjuvants for the U.S.
There is squalene in H1N1 vaccines licensed in Europe but not yet in the U.S. That is not to say the vaccine manufacturers will not try to get the adjuvants inserted into vaccines in the future, but for now we have won on this point.
Who Stands to Benefit From the Swine Flu Pandemic (and Future Pandemics)?
This is the question you need to ask yourself when you hear the media dishing out the latest statistics about the swine flu pandemic.
In the last few days alone, I’ve seen major news outlets warning that come flu season, the swine flu could kill 90,000 Americans and hospitalize 2 million. This sounds a lot like the fear-mongering that went on during the Bird Flu pandemic (that never materialized) back in 2005.
Back then scientists and governments were congratulating themselves for averting a threat that never was by stockpiling worthless vaccines. Now I’m having déjà vu.
In response to this newest swine flu pandemic, what did the Centers for Disease Control and Prevention recently suggest?
Swine flu shots for all! Of course, what else would you expect?
As the Washington Post reported, CDC said: “As soon as a vaccine is available, try to get it for everyone in your family.”
Well, you might be tempted to do just that if you believe the sensational number of swine flu deaths they’re predicting. But, really, these numbers are not based on facts.
WHO continues to define the severity of the H1N1 virus to be moderate, generally defined as an illness requiring neither hospitalization nor even medical care. Most cases are having MILD symptoms that clear up on their own.
Further, no one really knows for sure just how many cases of swine flu there are, because some countries are no longer confirming them by lab.
In the UK, for example, they now appear to be collecting swine flu data online and via the phone, based on nothing but self-assessment.
So did they really contract the swine flu?
Or did the vast majority of them simply have a case of the sniffles or a seasonal flu bug? Without laboratory confirmation, no one will ever know, but they sure are using those numbers to scare you!
Going back to my original question though, you must ask yourself who stands to benefit from all of this paranoia and hysteria.
Of course you know the answer to this one.
Big Pharma … which stands to gain up to $49 billion a year on the swine flu vaccine alone plus an infinite amount on top of that for future pandemic vaccines.
The vaccine manufacturers would love for every man, woman, and child to heed the CDC’s advice to get vaccinated. But now you know better.
The swine flu is typically a mild illness.
The swine flu vaccine has not been tested for safety or efficacy, but we DO know it will contain harmful additives.
The choice, to me, is obvious. And in the future, anytime a new “pandemic” appears and officials urge you to rush out and get a shot, please remember this article and ask yourself if it’s really you who stands to benefit from their advice.
Swine Flu Virus & Vaccines (Part 1)